APA (7th ed.) Citation

Borm, G., & Mannaerts, B. (2000). Treatment with the gonadotrophin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: Results of a controlled, randomized, multicentre trial. Human reproduction (Oxford), 15(7), 1490-1498. https://doi.org/10.1093/humrep/15.7.1490

Chicago Style (17th ed.) Citation

Borm, G., and B. Mannaerts. "Treatment with the Gonadotrophin-releasing Hormone Antagonist Ganirelix in Women Undergoing Ovarian Stimulation with Recombinant Follicle Stimulating Hormone Is Effective, Safe and Convenient: Results of a Controlled, Randomized, Multicentre Trial." Human Reproduction (Oxford) 15, no. 7 (2000): 1490-1498. https://doi.org/10.1093/humrep/15.7.1490.

MLA (9th ed.) Citation

Borm, G., and B. Mannaerts. "Treatment with the Gonadotrophin-releasing Hormone Antagonist Ganirelix in Women Undergoing Ovarian Stimulation with Recombinant Follicle Stimulating Hormone Is Effective, Safe and Convenient: Results of a Controlled, Randomized, Multicentre Trial." Human Reproduction (Oxford), vol. 15, no. 7, 2000, pp. 1490-1498, https://doi.org/10.1093/humrep/15.7.1490.